Ernexa Therapeutics Inc. (ERNA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ernexa Therapeutics Inc.

    NASDAQ: ERNA · Real-Time Price · USD
    1.36
    -0.01 (-0.73%)
    At close: Oct 09, 2025, 3:49 PM

    Ernexa Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 582K 68K n/a n/a
    Cost of Revenue
    		 96K 236K 497K 459K
    Gross Profit
    		 486K -168K -497K -459K
    Operating Income
    		 -15.67M -21.14M -26.95M -27.43M
    Interest Income
    		 249K 138K n/a n/a
    Pretax Income
    		 -44.51M -21.67M -24.53M -122.3M
    Net Income
    		 -44.54M -21.67M -24.58M -122.31M
    Selling & General & Admin
    		 13.13M 14.59M 16.06M 14.72M
    Research & Development
    		 4.6M 5.92M 10.39M 12.71M
    Other Expenses
    		 -1.58M 461K n/a -459K
    Operating Expenses
    		 16.16M 20.97M 26.45M 26.97M
    Interest Expense
    		 6.75M 614K 30K 74K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 16.26M 21.2M 26.95M 27.43M
    Income Tax Expense
    		 30K -3K 45K 64K
    Shares Outstanding (Basic)
    		 28.4M 5.31M 3.05M 2.17M
    Shares Outstanding (Diluted)
    		 28.4M 5.31M 3.05M 2.17M
    EPS (Basic)
    		 -1.57 -4.08 -8.06 -56.61
    EPS (Diluted)
    		 -1.57 -4.08 -8.06 -56.61
    EBITDA
    		 -36.12M -19.93M -24.01M -121.95M
    EBIT
    		 -37.76M -21.06M -24.5M -122.41M
    Depreciation & Amortization
    		 1.64M 1.12M 497K 459K

    Add to Watchlist